Holen Sie sich die Stockscreener-App
89.30
0.28%
0.25
Handel nachbörslich:
90.26
0.96
+1.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$89.05
Offen:
$88.9
24-Stunden-Volumen:
3.60M
Relative Volume:
0.86
Marktkapitalisierung:
$43.41B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
161.75
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
+7.54%
1M Leistung:
+5.78%
6M Leistung:
+12.12%
1J Leistung:
+42.02%
1-Tages-Spanne:
$88.05
$89.41
1-Wochen-Bereich:
$83.56
$89.60
52-Wochen-Spanne:
$61.76
$91.06
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, DOC, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
89.30 | 43.29B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
227.73 | 160.48B | 11.75B | 1.46B | 2.19B | -0.6014 |
DOC
Healthpeak Properties Inc
|
21.87 | 14.86B | 2.87B | 250.10M | 1.13B | 0.3188 |
OHI
Omega Healthcare Investors Inc
|
48.11 | 14.31B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
52.00 | 10.54B | 2.37B | 101.67M | 169.19M | 0.5775 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call - Business Wire
Are You Looking for a High-Growth Dividend Stock? - Yahoo Finance
Ventas adjusts senior leadership, REIT stock in sector focus - AD HOC NEWS
Ventas names head of outpatient medical research property unit - Crain's Chicago Business
Patton Fund Management Inc. Sells 60,624 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas Inc To Go Ex-Dividend On June 30th, 2026 With 0.52 USD Dividend Per Share - 富途牛牛
Ventas clears S&P 500 healthcare benchmark, shares reflect steady REIT profile - AD HOC NEWS
Chicago REIT Pays $32M for Little Rock Site (Real Deals) - Arkansas Business
The senior housing portfolio from Ventas Inc.stable rents and healthcare demand - AD HOC NEWS
Price to earnings forward of Ventas, Inc. – BOATS:VTR - TradingView
Is Ventas (VTR) Rewriting Its Risk Profile With New Outpatient Leadership And Interim Legal Steward? - Sahm
Is Ventas stock outperforming the Dow? - MSN
Ventas opens the week with a strategy focus, shares in the US healthcare REIT sector - Ad-hoc-news.de
Union Bancaire Privee UBP SA Acquires 33,030 Shares of Ventas, Inc. $VTR - MarketBeat
Sterling Capital Management LLC Cuts Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas opens the weekend with a clear strategy focus, shares on the NYSE radar - Ad-hoc-news.de
46,134 Shares in Ventas, Inc. $VTR Purchased by OP Asset Management Ltd - MarketBeat
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventyx Biosciences clarifies pipeline strategy, shares react to sector volatility - Ad-hoc-news.de
Ventas Inc. highlights senior housing growth, REIT shares in S&P 500 focus - Ad-hoc-news.de
Ventas updates its senior notes filing, REIT stock under investor scrutiny - Ad-hoc-news.de
Ventas (VTR) Citi’s Miami Global Property CEO Conference 2026 Summary - Quartr
Ventas, Inc. Actuals & Estimates (NYSE:VTR) - TradingView
Ventas, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh Actuals & Estimates (BMFBOVESPA:V1TA34) - TradingView
Price to sales forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to EBIT forward of Ventas, Inc. – NYSE:VTR - TradingView
Enterprise value to revenue forward of Ventas, Inc. – NYSE:VTR - TradingView
Ventas, Inc. Actuals & Estimates (BX:VEN) - TradingView
Is Holding Ventas Stock Still a Smart Move for Your Portfolio Now? - TradingView
Ventas Inc. updates leadership in outpatient medical properties, shares in S&P 500 healthcare real e - Ad-hoc-news.de
VTR Forecast — Price Target — Prediction for 2027 - TradingView
Friedenthal Financial Acquires Shares of 11,847 Ventas, Inc. $VTR - MarketBeat
SG Americas Securities LLC Has $25.48 Million Position in Ventas, Inc. $VTR - MarketBeat
Ventas Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Ventas announces leadership change in outpatient platform, shares in S&P 500 healthcare REIT focus - Ad-hoc-news.de
Ventas Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
The Senior Living Communities from Ventas Inc.healthcare real estate that runs quietly in the bac - Ad-hoc-news.de
Ventas Appoints Andrew L. Wattula as Executive Vice President of Outpatient Medical and Research - geneonline.com
Ventas, Inc. Announces Appointment of Andrew L. Wattula as Executive Vice President, Outpatient Medical & Research, Effective August 2026 - marketscreener.com
Diversified Trust Co Purchases 32,436 Shares of Ventas, Inc. $VTR - MarketBeat
Ventas StockAnalyst consensus and dividend profile in focus - AD HOC NEWS
Ventas Inc (VTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
World Investment Advisors Invests $1.91 Million in Ventas, Inc. $VTR - MarketBeat
Hsbc Holdings PLC Grows Stock Holdings in Ventas, Inc. $VTR - MarketBeat
Groupama Asset Managment Lowers Holdings in Ventas, Inc. $VTR - MarketBeat
Does Ventas’ Leadership Shuffle and EVP Exit to Blackstone Reframe Its Governance Narrative (VTR)? - simplywall.st
Why a senior housing campus from Ventas Inc. is drawing quiet attention - Ad-hoc-news.de
Forty three Eighteen Advisors LLC Makes New Investment in Ventas, Inc. $VTR - MarketBeat
Why Ventas’ wellness-focused senior living feels different at The Springs at Greer Gardens - Ad-hoc-news.de
Deutsche Bank Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $100 - 富途牛牛
Ventas Is Maintained at Sector Perform by Scotiabank - Moomoo
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):